Position in BBIO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,411,058
+$486,004 QoQ
Shares Held
45,934
+20.1% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026POLEN CAPITAL MANAGEMENT LLC holds $24,298,441 across 17 Biotechnology names. BBIO ranks #1 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
This page
|
45,934 | $3,411,058 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
10,043 | $3,235,754 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
24,337 | $2,565,119 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
51,951 | $2,553,911 | |
| 5 | CELC |
Celcuity Inc.
|
17,181 | $1,961,039 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
20,531 | $1,896,653 | |
| 7 | KOD |
Kodiak Sciences Inc.
|
41,354 | $1,576,414 | |
| 8 | TSHA |
Taysha Gene Therapies, Inc.
|
319,748 | $1,429,273 |
All Filings in BBIO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,411,058 | 45,934 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,925,054 | 38,241 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,878,358 | 36,164 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,539,323 | 35,649 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||